Daily Morning Note – 3 April 2018

WEEKLY MARKET OUTLOOK WEBINAR

Register HERE for MONDAY’s 11.15am webinar if you have not already done so.

Archived webinars available.

RESEARCH REPORT

Facebook Inc. – Buy Trade – Position Open
Recommendation: Positive, Last done price: USD 159.79
Target price: USD 220.00, Analyst: Ho Kang Wei, Jeremy Ng
– Entry Price: 159.79
– Stop Loss: 139.00
– Risk/Reward: 2.9
– Massive User Base and Digital Advertising Growth


TECHNICAL PULSE

Healthway Med Ltd – Daily timeframe – Bullish
– A bullish price action, hammer was formed on 02/04/18 with increasing
volume suggests a reversal higher next.
– Expect the long-term uptrend to resume next for price to test the 0.054
resistance area followed by 0.058.

For more information and additional disclosures, refer to the link here.

BREAKING NEWS

Clearbridge Health Limited has acquired a 85% stake in Medic Surgical Private Limited (MSPL) and Medic Laser Private Limited (MLPL) for S$5.5 million. MSPL and MLPL collectively operate a clinic under the name “Medic Surgery and Laser Clinic” in Tanjong Pagar.

Qualitas Medical, which is planning a listing on the mainboard of the Singapore Exchange (SGX), has lodged its preliminary prospectus with the Monetary Authority of Singapore.

SGX has flagged possible regulatory breaches at YuuZoo Corp and has issued a compliance notice to the Company.

SGX has reported YuuZoo Corp to the relevant authorities for possible breaches of the Securities & Futures Act.

SGX has issued a compliance notice to Midas Holdings, to remove Mr Chen Wei Ping and Mr Ma Ming Zhang from their respective executive appointments.

Singapore’s manufacturing activity grows for 19th straight month in March, as its Purchasing Managers’ Index (PMI) edged up to 53.0 from an earlier 52.7.

Tech Rout Sinks Stocks as Lines of Defense Crumble: Amazon hammered by Trump tweets; Apple plans hit Intel, S&P 500 closes below 200-day average for first time since 2016.

Source: SGX Masnet, The Business Times, Bloomberg, Phillip Securities Research

Clients of Phillip Securities can keep updated with Country Strategy and Singapore Sector Reports by logging into: www.poems.com.sg > STOCKS > Research

Read the research report(s), available through the link(s) above, for complete information including important disclosures

Important Information

Disclaimer
The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided “as is” without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.